- abnormal spleen morphology / IMPC
- abnormal placenta morphology / IMPC
- persistence of hyaloid vascular system / IMPC
- embryonic growth retardation / IMPC
- small spleen / IMPC
- preweaning lethality, complete penetrance / IMPC
- abnormal eye morphology / IMPC
- abnormal ovary morphology / IMPC
- abnormal kidney morphology / IMPC
- abnormal testis morphology / IMPC
- edema / IMPC
- abnormal blood vessel morphology / IMPC
- microphthalmia / IMPC
- increased circulating calcium level / IMPC
- enlarged kidney / IMPC
- enlarged testis / IMPC
- anophthalmia / IMPC
- abnormal placenta vasculature / IMPC
C57BL/6-Tcf21tm1Cstw/H
Status | Available to order |
EMMA ID | EM:15189 |
Citation information | RRID:IMSR_EM:15189 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6-Tcf21tm1Cstw/H |
Alternative name | TCF21-rtTA |
Strain type | Targeted Mutant Strains : Knock-in |
Allele/Transgene symbol | Tcf21-rtTA |
Gene/Transgene symbol | Tcf21 |
Information from provider
Provider | Christopher Switzer |
Provider affiliation | Queen Mary University of London |
Genetic information | Reverse Tet-off rtTA protein controlled by Tcf21 promoter (fibroblast-specific). A 9.1 kb region was first subcloned from a positively identified C57BL/6 fosmid clone (WI1-336E22) and used to build the targeting vector using homologous recombination-based techniques. The region is designed so that the long homology arm (LA) extends 6.2 kb upstream of the P2A-rtTA knock-in cassette and the short homology arm (SA) extends 2.3 kb downstream of the neo cassette. The P2A-rtTA cassette was inserted upstream of the TGA stop codon in exon 2 of the mouse Tcf21 gene. The FRT flanked neo selection cassette followed downstream of the 3’-UTR sequence. The targeting vector was confirmed by restriction analysis and sequencing after each modification step. The boundaries of the 2 homology arms were confirmed by sequencing with primers P6 and T73 that read through both sides of the backbone vector into the genomic sequences. The P2A-rtTA knock-in cassette was confirmed by sequencing with primers TCFC SQ1 and SQ2. IV-neo N3 and ineo N2 primers, reading from the selection cassette, confirmed the insertion of the neo cassette. The PTRE3G promoter has been used. |
Phenotypic information | Homozygous:No observable phenotypic differences.Heterozygous:No observable phenotypic differences. |
Breeding history | |
References | None available |
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (gene matching)
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).